Skip to content
Health

Who benefits from the panic around the new type of Corona virus? The situation is under control, and there is now cause for worrying. In the early 2000s, around 100 billion USD was spent to “contain the spread” of the SARS-Co virus. In 18 years, around 700 people have died from it – just as many who dies from a usual influenza. In this case, the big pharmaceutical companies could profit largely. Why this panic? The answer is the classical: “who benefits from it?”

Do big pharmaceutical companies profit from the panic around the new type of Corona virus?

Falseaccording to EUvsDisinfo

EUvsDisinfo checked this claim on 27 January 2020.

“disinformation”

  1. English

    Read the fact-check at EUvsDisinfo

Around this claim

First seen
27 January 2020, tsargrad.tv, according to EUvsDisinfo (EEAS East StratCom Task Force)

Where it turned up

  • Seen at tsargrad.tv, according to EUvsDisinfo (EEAS East StratCom Task Force), 27 January 2020

Related

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: EUvsDisinfo, European External Action Service. Licence: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.

The sources are the verdict.